Dr. Anthony Fauci said Gilead Sciences’ antiviral drug remdesivir will become the standard of care for COVID-19 after early results from a key clinical trial showed it helped patients recover more quickly
- The top U.S. infectious disease official said Gilead Sciences Inc’s experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early results from a key clinical trial on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.
“This will be the standard of care,” he said, adding “the FDA ... is working with Gilead to figure out mechanisms to make this easily available to those who need it.” Interest in Gilead’s drug has been high as there are currently no approved treatments or vaccines for COVID-19, and doctors are desperate for anything that might alter the course of the disease that attacks the lungs and can shut down other organs in severe cases, until a preventive vaccine emerges.
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease , during the outbreak of the coronavirus disease , in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake “The drug seems to have antiviral activity - how much is as yet unclear,” Dr. Daniel McQuillen, an infectious disease specialist at Lahey Hospital & Medical Center in Burlington, Massachusetts, told Reuters. “Seems likely that it might need use with another antiviral agent.”Gilead also provided data on a study in severe COVID-19 patients it has conducted in dozens of medical centers, which does not have a placebo comparison but tested the drug under five-day and 10-day regimens.
Gilead Chief Executive Daniel O’Day earlier this month said the company was prepared to donate 1.5 million doses of remdesivir to hospitals dealing with severely ill patients. Regulatory approval of the drug would also clear the way for commercial sales.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Dr. Anthony Fauci says data from remdesivir coronavirus drug trial shows 'quite good news'CNBC's Meg Tirrell breaks down White House health advisor Dr. Anthony Fauci's comments on Gilead's possible coronavirus treatment.
続きを読む »
Gilead reports 'positive data' on remdesivir coronavirus drug trial
続きを読む »
Coronavirus treatment: Gilead says positive data on remdesivir coming - Business InsiderOne of the most promising coronavirus treatment candidates succeeded in a late-stage trial in COVID-19 patients, Gilead said Wednesday.
続きを読む »
What to watch today: Dow set to jump on positive data on possible Gilead coronavirus treatmentDow futures soar on positive data about a possible Gilead Sciences coronavirus treatment.
続きを読む »
Stocks Rally, Dow Up 400 Points After Gilead Treatment Shows ‘Positive Data’The market got a boost from news of a potential treatment for coronavirus.
続きを読む »
Gilead Sciences says there are 'positive data' from a study on possible Covid-19 treatment remdesivirThere's 'positive data' emerging from a study on possible Covid-19 treatment remdesivir, the maker of the investigational drug says
続きを読む »